Style de citation APA (7e éd.)

A, A., N, B., R, C., T, W., G, M., M, H., . . . JJ, C. (2017). Long-term safety and efficacy of biosimilar infliximab among patients with inflammatory arthritis switched from reference product. Dove Medical Press.

Style de citation Chicago (17e éd.)

A, Abdalla, Byrne N, Conway R, Walsh T, Mannion G, Hanly M, O'Sullivan M, Curran AM, et Carey JJ. Long-term Safety and Efficacy of Biosimilar Infliximab Among Patients with Inflammatory Arthritis Switched from Reference Product. Dove Medical Press, 2017.

Style de citation MLA (8e éd.)

A, Abdalla, et al. Long-term Safety and Efficacy of Biosimilar Infliximab Among Patients with Inflammatory Arthritis Switched from Reference Product. Dove Medical Press, 2017.